JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shemano, I.
Right arrow Articles by Nickerson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shemano, I.
Right arrow Articles by Nickerson, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Hazardous Substances DB
*NITROPHENOLS
Journal of Pharmacology And Experimental Therapeutics, Vol. 139, Issue 1, 88-93, 1963
Copyright © 1963 by American Society for Pharmacology and Experimental Therapeutics


MECHANISMS OF THERMAL RESPONSES TO 2,4-DINITROPHENOL

Irving Shemano 1 and Mark Nickerson 1

1 Department of Pharmacology and Therapeutics, University of Manitoba Faculty of Medicine, Winnipeg, Manitoba, Canada

2,4-Dinitrophenol (DNP) produced a consistent hyperthermia in lightly restrained rats at ambient temperatures above 20 to 22°C, and a hypothermia at lower ambient temperatures. DNP failed to affect body temperature in curarized rats at a low ambient temperature. DNP produced a smaller increase in oxygen consumption of lightly restrained rats at lower ambient temperatures.

In contrast to its effects in rats, DNP in doses of 3.0 and 20 mg/kg did not affect the body temperature of lightly restrained dogs at low ambient temperatures (10 and 4°C). Visible shivering was not noticeably influenced by the dose of 3.0 mg/kg but was greatly diminished by 20 mg/kg. A relative hyperthermia was produced in dogs completely paralyzed with a neuromuscular blocking agent at all ambient temperatures studied (5 to 20°C). The hyperthermia was due to increased heat production which was not significantly different at different ambient temperatures.

Intracarotid infusion of a small dose of DNP in "curarized" dogs over a 10-minute period produced a much smaller increase in oxygen consumption than did intravenous infusion of the same dose.

These results indicate that the hypothermic effect of DNP probably is due to both a centrally-mediated inhibition of the skeletal muscle thermogenic response to cold and to a reduced metabolic effect of DNP at low ambient temperatures. The hyperthermic effect of DNP, on the other hand, probably can be attributed entirely to a peripherally-mediated thermogenic action.

Submitted on March 27, 1962
Accepted on October 24, 1962







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1963 by the American Society for Pharmacology and Experimental Therapeutics.